nirf-ivus
(2)
Intravascular Imaging Incorporated (i3)
Intravascular Imaging Incorporated (i3) is a Wilton, Connecticut medical device company building a next-generation coronary imaging catheter. Its 3-French NIRF-IVUS catheter fuses intravascular ultrasound (IVUS), the clinical standard for guiding stent placement, with near-infrared fluorescence (NIRF) molecular imaging in a single device. The combination lets cardiologists see not just the anatomy of a coronary artery but the biology inside it - plaque inflammation, arterial dissections, transplant vasculopathy, and fibrin in unhealed stents. Spun out of work at Massachusetts General Hospital/Harvard Medical School and the Technical University of Munich, i3 aims to upgrade percutaneous coronary intervention (PCI) by helping doctors look beyond anatomy.
R. Scott Jones
R. Scott Jones is the Chairman and CEO of Intravascular Imaging Incorporated (i3), a Wilton, Connecticut medtech startup commercializing a 3-French NIRF-IVUS catheter that lets cardiologists see both the anatomy and the biology of a diseased coronary artery in a single pass. A medical device operator with more than 25 years in the field, he once ran GE Medical Systems' cardiovascular business across the Americas and Asia and has steered companies from two-person startups to organizations of 7,000 employees. At i3 he is the commercial engine behind a technology born in the labs of Massachusetts General Hospital and the Technical University of Munich.